Yasushi Yatabe - Concepedia

Author

Yasushi Yatabe

Also Known As

A Sawaki, Corvalan, Alejandro H, Dario Greco, Fernando Meneses‐Gonzalez, Hongji Dai, Katsuyuki Kiura, Koichi Goto, Noriko Yanagitani, Norio Hayashi, Peter Hillemanns

1.2K

Publications

70.6K

Citations

115

H-Index

211

Concepts

All Affiliations

Aichi Cancer Center Nagoya University Tokyo National Hospital National Cancer Center Hospital East Nagoya City University

About

Yasushi Yatabe is an author at Aichi Cancer Center specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	78	255	26.6K
2	Health Sciences	25	40	3.9K
3	Public Health	13	13	610
4	Engineering	9	9	447
5	Natural Sciences	4	4	204

Yasushi Yatabe

459

Publications

50.4K

Citations

105

H-Index

Page 1

	Year	Citations
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Tetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, The Lancet Oncology Open LabelMedicineCancer GrowthPathologyCancer Genomics	2009	4.1K
Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival Junichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa, Cancer Research	2004	2.4K
Comprehensive genomic profiles of small cell lung cancer Julie George, Jing Lim, Se Jin Jang, Nature Cancer GenomicsBronchial NeoplasmComprehensive Genomic ProfilesMolecular DiagnosticsRadiation Oncology	2015	2.3K
A Polycistronic MicroRNA Cluster, <i>miR-17-92</i> , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation Yoji Hayashita, Hirotaka Osada, Yoshio Tatematsu, Cancer Research	2005	1.5K
Mutations of the <b> <i>Epidermal Growth Factor Receptor</i> </b> Gene in Lung Cancer Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Cancer Research	2004	1.2K
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors Young Lim Choi, Manabu Soda, Yoshihiro Yamashita, New England Journal of Medicine PathologyFusion-type Tyrosine KinaseCancer BiologyAnaplastic Lymphoma KinaseTumor Biology	2010	1.2K
Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence Tetsuya Mitsudomi, Takayuki Kosaka, Hideki Endoh, Journal of Clinical Oncology	2005	956
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Archives of Pathology & Laboratory Medicine	2018	887
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa, PubMed PathologyCox-2 ExpressionCancer BiologyTumor BiologyCancer Cell Biology	1998	825
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project Ming‐Sound Tsao, Keith M. Kerr, Mark Kockx, Journal of Thoracic Oncology Real-life Clinical SamplesBiomarker (Medicine)Translational MedicineBlueprint Phase 2Immunocytochemical Technique	2018	793

Page 1